Loading...
First Round of Abstract Submission Ends: Dec 31, 2026
Extended Early Bird Ends: Oct 28, 2026

Plenary Speakers

Prof. FangXiang WU
University of Saskatchewan, Canada
Title: Advancing Bioinformatics with Artificial Intelligence
Dr. FangXiang Wu is currently a full professor in the Departments of Computer Science, the Division of Biomedical Engineering, and the Department of Mechanical Engineering at the University of Saskatchewan. He is a Fellow of the Engineering Institute of Canada (EIC) (for his exceptional contributions to artificial intelligence, computational biology, medical image analysis and complex bionetwork analytics), a Fellow of the Institute of Electrical and Electronics Engineers (IEEE) (for contributions to computational intelligence techniques for biomedical data analytics), a Fellow of the Institution of Engineering and Technology (IET), and a Fellow of the Asia-Pacific Artificial Intelligence Association (AAIA). He is a recipient of the University of Saskatchewan Distinguished Researcher Award (the institution’s highest research honor).

Dr Wu’s research interests include Artificial Intelligence, Machine/Deep Learning, Computational Biology, Health Informatics, Medical Image Analytics, and Complex Network Analytics. He has published over 500 journal/conference papers. His total Google scholar citations are over 20,000 and h-index is 77. Dr Wu is serving as the editorial board member of several international journals (including IEEE TCBB, Neurocomputing, etc.) and as the guest editor of numerous international journals, and as the program committee chair or member of many international conferences.
Prof. Peter Zilla
University of Cape Town, South Africa
Title: Transcatheter Heart Valve Prostheses for Young Patients: From Immune-Masked Bioprostheses to Polymer Leaflets
Professor Zilla’s academic qualifications are an MD (University of Vienna), DrMed. (University of Zurich); PD; (University of Vienna) and PhD (University of Cape Town). He is a registered general-, vascular- and cardiothoracic surgeon. After 3 years in basic science (University Zurich 1981-1983); he did his surgical residency at the University Hospital Vienna (1983-1989) and senior-residency at the University Hospital Zurich (1989-1990); held staff-surgeon positions in Austria and Cape Town and has been Chair of the Chris Barnard Department of Cardiothoracic Surgery for two decades until 2021 when he became Emeritus Professor and Senior Research Scholar. He is also Adjunct Professor at the Medical University of Vienna.

He published 232 peer-reviewed full papers; holds 46 US/PCT patents and has an H-index of 63 /i10 of 195. He initiated the ‘Cardiac Surgery Intersociety Alliance (CSIA), an umbrella body uniting all major global cardiothoracic societies with the goal of fostering the surgical capacity of developing countries.

He had previously pioneered clinical cardiovascular tissue engineering in the 1990s culminating in >500 patients having received autologous in-vitro endothelialised vascular grafts convincingly showing the clinical potential of tissue engineering. His second research focus emerged out of the dire needs of developing countries to have long-lasting soft-leaflet heart valve prostheses available for the millions of largely young patients with rheumatic heart disease.

As an entrepreneur, he initiated an academic–industry partnership with Medtronic (from 1991-2011), generating 22 PCT/US patents with translational impact, including technologies commercialised in vascular graft support and bioprosthetic tissue treatment. He subsequently founded Strait Access Technologies (2012), advancing a transcatheter polymer valve platform (including flow-permissive balloon systems), achieving FDA clearance for TEVAR (2025), initiating US clinical use and first-in-human TAVR studies with their TAVR system, raising ~USD 33 million. He subsequently founded ‘Cyrion’, a spin-off developing a surgical polymer mitral valve with the Leducq Foundation.
Prof. Jian-Jiang Zhong
Shanghai Jiao Tong University, China
Title: Advances in Biomanufacturing Technology
Dr. JJ Zhong is a distinguished professor at Shanghai Jiao Tong University, China. His research interests include biotechnology, biochemical engineering, metabolic engineering and synthetic biology. He has published over 270 papers in peer-reviewed international journals. He was awarded the Cheung Kong Scholar Professorship from the Ministry of Education (MOE), National Science Fund for Distinguished Young Scholars by National Natural Science Foundation of China, the inaugural award of "Young Asian Biotechnologist Prize" by the Society for Biotechnology (Japan), the 1st-class Prize for Advancement of Science & Technology by MOE for twice (in 2004 & 2014), and the "Research Exchange Award" from the Korean Society for Biotechnology and Bioengineering. He is on the editorial board of 10 SCI-cited international journals and was a plenary/invited speaker in about 90 international conferences.
Prof. Ji-Dong Gu
Guangdong Technion Israel Institute of Technology, China
Title: Advances in Biotechnology for Protection of World Cultural Heritage
Ji-Dong Gu is currently a full professor of the Environmental Science and Engineering Department, Guangdong Technion - Israel Institute of Technology and also Israel Institute of Technology concurrently. He obtained his M.Sc. from University of Alberta (Canada), and Ph.D. from Virginia Tech (USA). After a brief post-doc at University of Massachusetts – Lowell, he joined Ralph Mitchell’s Laboratory at Harvard University for 6 years before taking a faculty position at The University of Hong Kong. After working for more than 21 years, he resigned from the University of Hong Kong and then started his new full-time position with Guangdong Technion - Guangdong Israel Institute of Technology and Technion - Israel Institute of Technology in 2020.

His recent research interest includes: 1) carbon and nitrogen cycling, including anaerobic ammonium oxidation and nitrite-dependent anaerobic methane oxidation; 2) oil field microbiology for enhanced oil recovery and pollution remediation; and 3) microbiology of cultural heritage.

His H-index is 98, i10-index 521, and total citations of 35,705 (GoogleScholar). He has been the world top 1% scientists by WoS since 2013. He has published in the areas of applied and environmental microbiology and toxicology with more than 500 refereed scientific journal papers, 42 book chapters. He co-edited a book with Ralph Mitchell on ‘Environmental Microbiology’ (2nd ed, John Wiley-Blackwell. 2010).

He is the editor-in-chief for International Biodeterioration & Biodegradation (2015– ) and Sustainable Biotechnology (2026– )(a new journal to be launched); and editor for Global Heritage, npj Heritage Science, and Studies in Conservation.
Prof. Frederick H. Silver
Rutgers, The State University of New Jersey, USA
Title: The Use of Photonics and Vibronics to Study Mechanobiology and Pathobiology of Disease
Dr. Frederick H. Silver is a Professor of Pathology and Laboratory Medicine at Robert Wood Johnson Medical School, Rutgers, the State University of New Jersey. He did his Ph.D. in Polymer Science and Engineering at M.I.T. with Dr. Ioannis Yannas, the inventor of the Integra artificial skin, followed by a postdoctoral fellowship in Developmental Medicine at Mass General Hospital in Boston, MA with Dr. Robert L. Trelstad, a connective tissue pathologist. Dr. Silver invented in his lab at Rutgers a new technique termed vibrational optical coherence tomography (VOCT). US and European patents have been granted on VOCT to Rutgers on vibrational evaluation of materials and tissues. The issued patent has been licensed to OptoVibronex, LLC. a startup company co-founded by Dr. Silver and Lisa Silver. This technology can be used to provide a non-invasive “virtual biopsy” of tissues including skin cancers and ocular tissues. This technology can be used with telemedicine to provide images and quantitative mechanovibrational data that along with AI can be used to remotely provide information used in making personalized medical diagnoses. His interests include applying new engineering techniques that can be used to assess the structure and properties of extracellular matrix in health and disease and the role of mechanobiology in tissue mechanical homeostasis. A breakthrough device designation has been issued by the US FDA to OptoVibronex to facilitate the approval process and to assist the Dermatologist to identify the margins and depth of skin lesions noninvasively. Dr. Silver has published over 250 peer reviewed scientific papers, 4 textbooks on biomaterials and biomedical engineering, and has over 20 patents issued and pending. He has taught biomedical engineering students at Boston University, University of Minnesota, and Rutgers for over 40 years. He is an academic editor for the MDPI Journal Biomolecules.
Prof. Jiri Bartek
Danish Cancer Society, Denmark
Title: Cell cycle and genome integrity controls: Mechanisms and relevance for cancer development and treatment
Jiri Bartek is a globally recognized authority in the field of DNA damage response and genome integrity. He is a professor of cancer biology at the Karolinska Institute, Stockholm, and holds parallel group leader appointments since 2015, at the Danish Cancer Society in Copenhagen and the Karolinska Institute. His work focuses on mechanistic aspects of cell cycle regulation, checkpoint pathways, genome (in)stability and cancer development, complemented by translational work towards new treatments of cancer. With close to 600 peer-reviewed publications including numerous papers in Nature, Cell and Science, well over 100.000 citations, and his current h-Index around 150, he is the most cited cancer researcher in Scandinavia and among the most cited European scientists in cell biology and cancer research. J. Bartek is a long-term member of EMBO, frequent invited speaker at prestigious conferences, and his achievements have been acknowledged by a range of prestigious awards in multiple countries. He obtained his MD and PhD degrees in the Czech Republic, before his postdoctoral research at the Imperial Cancer Research Fund Laboratories in London (now the CRUK/Crick Institute) and the German Cancer Research Center in Heidelberg, followed by his appointments in the Czech Republic, Denmark and Sweden. He has a broad network of collaborators and supervised a large number of young scientists, many of whom are now successful group leaders and professors in related fields of biomedicine in diverse countries on several continents.
Prof. Buyong Ma
Shanghai Jiao Tong University, China
Title: Emerging of Dynamic Conformation Based Drug Design
Buyong Ma is a professor in the school of pharmacy, Shanghai Jiao Tong University.
Editor-in-Chief： BioChem (MDPI)
Editor-in-Chief： BME Horizon
Dr. Ma received his Ph.D. in physical chemistry from the University of Georgia at Athens in 1995. He joined NCI/NIH in 1998 and moved to current position in 2020. He has made outstanding contributions to computer-aided antibody drug design, biomacromolecular structure and interactions, and protein-protein interactions and functions. He proposed the conformational selection theory of biomolecular recognition, which has become a model alongside the classic 'Lock-Key' and 'Induced Fit' models. He was the first in the world to reveal the structure of the Aβ amyloid associated with Alzheimer's disease. His research findings have been extensively cited in areas such as the characterization of protein structure dynamics, enzyme catalysis, protein-protein interactions and drug design, and neurodegenerative diseases, thereby advancing progress in these fields.